09/08/2025
10:46 AM | FMR LLC (Filed by)
Zenas BioPharma (Subject)
| Form SCHEDULE 13G/A | |
09/02/2025
6:15 AM | Zenas BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2025
7:02 AM | Zenas BioPharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/12/2025
6:13 AM | Zenas BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2025
6:23 AM | Zenas BioPharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/06/2025
11:19 AM | FMR LLC (Filed by)
Zenas BioPharma (Subject)
| Form SCHEDULE 13G/A | |
06/12/2025
3:58 PM | Nunn Jason Raleigh (Reporting)
Zenas BioPharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
3:30 PM | MOULDER LEON O JR (Reporting)
Zenas BioPharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
3:31 PM | Lu Hongbo (Reporting)
Zenas BioPharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
3:32 PM | ORLOFF JOHN J (Reporting)
Zenas BioPharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
3:33 PM | ENRIGHT PATRICK G (Reporting)
Zenas BioPharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for ZBIO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Zenas BioPharma and its competitors with MarketBeat's FREE daily newsletter. |
06/12/2025
3:34 PM | Fairmount Funds Management LLC (Reporting)
Fairmount Healthcare Fund II L.P. (Reporting)
Harwin Peter Evan (Reporting)
Kiselak Tomas (Reporting)
Zenas BioPharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
3:35 PM | Farmer Joseph L (Reporting)
Zenas BioPharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
3:35 PM | Allen Patricia L (Reporting)
Zenas BioPharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
3:36 PM | Boylan James P (Reporting)
Zenas BioPharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2025
5:56 AM | Zenas BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2025
6:14 AM | Zenas BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2025
6:25 AM | Zenas BioPharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/28/2025
6:00 AM | Zenas BioPharma (Filer)
| Form DEF 14A | |
04/28/2025
6:02 AM | Zenas BioPharma (Filer)
| Form DEFA14A | |
04/28/2025
6:05 AM | Zenas BioPharma (Filer)
| Form ARS | |
04/28/2025
6:07 AM | Xiao Ting (Reporting)
Zenas BioPharma (Issuer)
| Form 4/A | |
04/01/2025
8:47 PM | Novo Holdings A/S (Filed by)
Zenas BioPharma (Subject)
| Form SCHEDULE 13G | |
03/11/2025
5:51 AM | Zenas BioPharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/11/2025
5:15 AM | Zenas BioPharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/05/2025
6:17 AM | Zenas BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2024
3:30 PM | Oliveira Orlando (Reporting)
Zenas BioPharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
3:31 PM | Fox Jennifer A. (Reporting)
Zenas BioPharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2024
4:20 PM | MOULDER LEON O JR (Reporting)
Zenas BioPharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
9:40 AM | FMR LLC (Filed by)
Zenas BioPharma (Subject)
| Form SC 13G | |
11/12/2024
6:17 AM | Zenas BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/21/2024
3:18 PM | Xencor Inc (Filed by)
Zenas BioPharma (Subject)
| Form SC 13G | |
